Last updated July 18, 2026
Key finding
BSP significantly reduced fasting blood glucose concentration (p < 0.001).
The study evaluated the efficacy of Boscisucrophage in patients with Type 2 Diabetes who were resistant to oral antihyperglycemic drugs, finding significant reductions in fasting plasma glucose and HbA1c levels.
Quick read
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Risk of bias
Some Concerns
Save research, organize studies, and quickly find important evidence again.
Plain-language summary
A plain-language read of the study’s main message and where it applies.
Study focus
The study evaluated the efficacy of Boscisucrophage in patients with Type 2 Diabetes who were resistant to oral antihyperglycemic drugs, finding significant reductions in fasting plasma glucose and HbA1c levels.
This study highlights a potential new treatment option for patients with Type 2 Diabetes who do not respond to conventional oral medications. By demonstrating significant improvements in key glycemic indicators, Boscisucrophage could offer a valuable alternative for managing blood sugar levels, ultimately improving patient outcomes and quality of life.
The study design was observational, limiting causal inferences. Sample size and demographic details were not provided. Long-term effects and safety of Boscisucrophage remain unclear.
Published in
Publication details and source links for this paper.
Bruno E, Amal E, Fahd AN, et al. Efficacy of Boscisucrophage in Type 2 Diabetes Patients Resistant to Oral Antihyperglycemic Drugs. Food Science & Nutrition. 2026;14(3):e71621. doi:10.1002/fsn3.71621
Boscisucrophage reduced fasting plasma glucose by 219.5 mg/dL (p < 0.001).
Boscisucrophage decreased HbA1c levels by 2.5% (p < 0.0001).
Boscisucrophage increased urinary glucose excretion.
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Boscisucrophage (Boscia senegalensis extract) and AST, Alanine Aminotransferase (ALT), Change in functional symptoms of T2DM, and 4 more.
This study contributes evidence to
Primary intervention
Boscisucrophage (Boscia senegalensis extract)
Primary outcomes
Evidence topics
Primary intervention
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
2
Related topics
7
Evidence pairs
555
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.
Primary evidence
Evidence topic
matched_outcome
Related evidence
Evidence topic
Save evidence
Core evidence
The primary outcomes reported in this study.
Boscisucrophage (Boscia senegalensis extract) → Alanine Aminotransferase (ALT)
Boscisucrophage (Boscia senegalensis extract) → Alanine Aminotransferase (ALT)
Boscisucrophage (Boscia senegalensis extract) → AST
Boscisucrophage (Boscia senegalensis extract) → AST
Boscisucrophage (Boscia senegalensis extract) → Change in functional symptoms of T2DM
Boscisucrophage (Boscia senegalensis extract) → Change in functional symptoms of T2DM
Boscisucrophage (Boscia senegalensis extract) → Fasting Plasma Glucose (FPG)
Boscisucrophage (Boscia senegalensis extract) → Fasting Plasma Glucose (FPG)
Boscisucrophage (Boscia senegalensis extract) → HbA1c
Boscisucrophage (Boscia senegalensis extract) → HbA1c
Boscisucrophage (Boscia senegalensis extract) → Serum creatinine
Boscisucrophage (Boscia senegalensis extract) → Serum creatinine
Boscisucrophage (Boscia senegalensis extract) → Urine glucose excretion (UGE)
Boscisucrophage (Boscia senegalensis extract) → Urine glucose excretion (UGE)
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Boscisucrophage (Boscia senegalensis extract) and Adipokine and Angiogenic Markers, Boscisucrophage (Boscia senegalensis extract) and AST.
This study contributes to the evidence on the following intervention-outcome relationships.
Curated evidence collections and hubs this study is part of.
All studies measuring Adipokine and Angiogenic Markers
Measures Adipokine and Angiogenic Markers as a key outcome.
All studies measuring AST
Measures AST as a key outcome.
All studies on Boscisucrophage (Boscia senegalensis extract)
Contributes to Boscisucrophage (Boscia senegalensis extract) evidence base.
Latest published studies
Published within the last 2 years.
Jump to pre-filtered views in Evidence Explorer.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Boscisucrophage (Boscia senegalensis extract) appears to improve Change in functional symptoms of T2DM.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Change in functional symptoms of T2DM
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Boscisucrophage (Boscia senegalensis extract) appears to improve Fasting Plasma Glucose (FPG).
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Fasting Plasma Glucose (FPG)
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Boscisucrophage (Boscia senegalensis extract) appears to improve HbA1c.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Boscisucrophage (Boscia senegalensis extract) for AST.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
AST
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Follow the topics this study contributes to.
Open broader Evidence Explorer views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.
